Braquiterapia de baja tasa como monoterapia en el tratamiento del cáncer de próstata de bajo riesgo

  1. Dominguez Morcillo, Marta
Dirixida por:
  1. Concepción López Carrizosa Director
  2. José Fermín Pérez-Regadera Gómez Director

Universidade de defensa: Universidad Complutense de Madrid

Fecha de defensa: 26 de febreiro de 2021

  1. José Luis Carreras Delgado Presidente
  2. Carmen González San Segundo Secretaria
  3. C. Rubio Rodríguez Vogal
  4. Rosa Morera López Vogal
  5. Juan de Dios Sáez Garrido Vogal
  1. Radiología, Rehabilitación y Fisioterapia

Tipo: Tese


Low dose rate brachytherapy (LDR) is an accepted treatment, effective and with few side effects at the local level, which is used as monotherapy in patients with low-risk prostate cancer. There are solid data that show local control and survival rates similar to those of other techniques such as external radiotherapy or radical surgery, with a lower risk of genitourinary and gastrointestinal side effects. OBJECTIVES: The aim of this work is to analyze 245 patients treated with this technique in the Radiotherapy Oncology Service of Gomez Ulla Hospital, from 2004 to 2016, we will eval-uate the relationship of the dosimetric parameters with the biochemical and local failure as well as the genitourinary and gastrointestinal toxicity derived from the technique. We will discuss if the results obtained are comparable to those reported in literature...